This suggests that this model could be used for screening therapeutic agents that may prevent HHI and that infants homozygous for the SUR1 R1420H variation would benefit from diazoxide use to reduce their hyperinsulinaemia. This evidence concerns the gene ABCC8 and familial hyperinsulinism.